Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 13.88 million. The enterprise value is 42.45 million.
Market Cap | 13.88M |
Enterprise Value | 42.45M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
Earnings Date | Nov 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 26.95 million shares outstanding. The number of shares has increased by 137.33% in one year.
Current Share Class | 26.79M |
Shares Outstanding | 26.95M |
Shares Change (YoY) | +137.33% |
Shares Change (QoQ) | -0.25% |
Owned by Insiders (%) | 45.26% |
Owned by Institutions (%) | n/a |
Float | 14.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.96 |
PB Ratio | -0.47 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.38 |
EV / Sales | 2.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24
Current Ratio | 0.24 |
Quick Ratio | 0.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.23 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -11.46% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 6.66% |
Revenue Per Employee | 314,403 |
Profits Per Employee | -124,957 |
Employee Count | 46 |
Asset Turnover | 2.52 |
Inventory Turnover | 1.70 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.65% in the last 52 weeks. The beta is 1.13, so Biotricity's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | +58.65% |
50-Day Moving Average | 0.56 |
200-Day Moving Average | 0.47 |
Relative Strength Index (RSI) | 39.04 |
Average Volume (20 Days) | 25,685 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.66 |
Income Statement
In the last 12 months, Biotricity had revenue of 14.46 million and -5.75 million in losses. Loss per share was -0.23.
Revenue | 14.46M |
Gross Profit | 11.32M |
Operating Income | -1.05M |
Pretax Income | -5.40M |
Net Income | -5.75M |
EBITDA | -1.04M |
EBIT | -1.05M |
Loss Per Share | -0.23 |
Balance Sheet
The company has 1.50 million in cash and 26.58 million in debt, giving a net cash position of -25.08 million or -0.93 per share.
Cash & Cash Equivalents | 1.50M |
Total Debt | 26.58M |
Net Cash | -25.08M |
Net Cash Per Share | -0.93 |
Equity (Book Value) | -29.32M |
Book Value Per Share | -1.23 |
Working Capital | -16.66M |
Cash Flow
Operating Cash Flow | -1.26M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 78.26%, with operating and profit margins of -7.26% and -37.33%.
Gross Margin | 78.26% |
Operating Margin | -7.26% |
Pretax Margin | -37.33% |
Profit Margin | -37.33% |
EBITDA Margin | -7.22% |
EBIT Margin | -7.26% |
FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -137.33% |
Shareholder Yield | n/a |
Earnings Yield | -41.41% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
Last Split Date | Jul 3, 2023 |
Split Type | Reverse |
Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -33.82 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -33.82 |
Piotroski F-Score | 4 |